Press

25+ EMERGING MEDICAL TECHNOLOGY CEOS TO PRESENT THEIR OPPORTUNITIES ONLINE AUGUST 11, 2010, HOSTED BY LIFE SCIENCE INTELLIGENCE

HUNTINGTON BEACH, Calif.-July 8, 2010--(BUSINESS WIRE)--Life Science Intelligence (LSI) announced today that more than 25 medical device companies with emerging technologies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on August 11, 2010 at 11 a.m. Eastern, sponsored by Rutan, with additional sponsorships available.

The program will feature select privately-held companies that are:

• At various stages of development
• Aiming to disrupt several medical device markets
• Seeking partnerships or licensing deals with larger medical technology companies
• Seeking investors
• Seeking acquisition

LSI’s Emerging Medical Technologies Spotlight is a travel-free online conference, which serves as a convenient forum for medical technology innovators, investors, and dealmakers to connect and collaborate from their desktops.  Registered attendees and select LSI members, which include the top medtech dealmaking companies and investment firms, will have an opportunity to quickly and efficiently preview these innovative companies and then selectively network with the CEOs.

Attendees to the meeting will get online access to:

• 10-15 minute CEO Presentations - audio and slides
• The Notebook of Executive Summaries
• Detailed Information, Including:  Development Stage, Competitive Landscape and Positioning, Technological Advantage, Target Markets, Sales Forecasts, Strategic Partnering Opportunities, Financial & Fund Raising Status, Management Team, IP Position, Exit Strategy, Contact Details
• The “Live” Event on August 11, 2010 and the “Replay” for up to 12 Months Thereafter
• Optional Networking

Companies on the August 11th program include:  Aespira, CerMed, CritiSense, CytoSorbents, Genomic Expression, Headway, ImmunoChemistry Technologies, Intellewave, IVDiagnostics, Magellan Spine Technologies, Micronics, NuOrtho Surgical, Omniflo, Omnivus, OrthoAccel Technologies, Pluristem Therapeutics, Pro-IV Medical, Redi-Tech Medical Products, Silere Medical Technology, SMT R&D, SpineSmith, Stellarray, TechniScan Medical Systems, TonoGuard, and VasoNova. 

LSI's online venue provides CEOs of emerging medical device technologies with a secure platform to efficiently share their business development and investment opportunities to a prominent investment and partnering audience.  Interested entrepreneurs may apply to present for the August 11th meeting.

To register to attend online or for additional details, visit www.EMTspotlight.com. 

About Life Science Intelligence (LSI)®
LSI delivers high-quality market data and competitive intelligence to medical technology executives, entrepreneurs, and investors.  LSI produces the comprehensive Emerging Medical Technologies® database, quarterly Emerging Medical Technologies® online meetings, traditional market reports, deeply segmented and frequently updated market agents, and global custom market research.  www.LifeScienceIntelligence.com

Contact:
Life Science Intelligence
Scott Pantel, 1-714-847-3540
scott@LifeScienceIntelligence.com